DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Elon Musk - 1 Musk - 1 Neuralink - 1 Noland Arbaugh - 1 Wednesday's - 1 DJ Seo - 1 Matthew MacDougall - 1
Top related locs:
U.S Barrow Phoenix , Arizona Neuralink
Top related orgs:
BCI - 1 Neuroscience - 1 U.S . Food - 1 Drug Administration - 1 Barrow Neurological - 1 FDA - 1 Wall Street - 1 CNBC - 1

Search resuls for: "Barrow Neurological"


3 mentions found


☆ Musk says next Neuralink brain implant expected soon, despite issues with the first patient
  + stars: | 2024-07-10 | by ( Ashley Capoot | In | ) www.cnbc.com   time to read: +3 min
Elon Musk said Wednesday that his brain tech startup Neuralink hopes to implant its system in a second human patient within "the next week or so." No BCI company has received approval from the U.S. Food and Drug Administration to commercialize their devices. In a livestream with Neuralink executives Wednesday, Musk said the company is hoping to implant its device in the "high single digits" of patients this year. However, in the weeks following the procedure, Neuralink said some threads from the implant retracted from Arbaugh's brain. Musk and the Neuralink executives said during Wednesday's livestream that only around 15% of the channels in Arbaugh's implant are functional.
Persons: Elon Musk, Musk, Neuralink, Noland Arbaugh, Wednesday's, DJ Seo, Matthew MacDougall Organizations: BCI, Neuroscience, U.S . Food, Drug Administration, Barrow Neurological, FDA, Wall Street, CNBC Locations: U.S, Barrow, Phoenix , Arizona, Neuralink
☆ Musk's brain implant company in search of human trials partner
  + stars: | 2023-03-27 | by ( Marisa Taylor Rachael Levy | Marisa Taylor | Rachael Levy | ) www.reuters.com   time to read: +3 min
March 27 (Reuters) - Elon Musk's brain implant company Neuralink has approached one of the biggest U.S. neurosurgery centers as a potential clinical trials partner as it prepares to test its devices on humans once regulators allow for it, according to six people familiar with the matter. Barrow has helped standardize brain implant surgeries in which the patient can remain asleep, a key step in making it more acceptable to a broad set of the population, Ponce said. This is in line with Musk's vision for Neuralink's brain chip. The billionaire CEO of Tesla Inc (TSLA.O) and majority owner of Twitter has said Neuralink's brain implants will become as ubiquitous as Lasik eye surgery. Neuralink's implant is a brain computer interface (BCI) device, which uses electrodes that penetrate the brain or sit on its surface to provide direct communication to computers.
☆ Experimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concerns
  + stars: | 2022-11-29 | by ( Jacqueline Howard | ) edition.cnn.com   time to read: +11 min
It involved 1,795 adults, ages 50 to 90, with mild cognitive impairment due to early Alzheimer’s disease or mild Alzheimer’s disease-related dementia. Such a score is consistent with early Alzheimer’s disease, with a higher number associated with more cognitive impairment. By 18 months, the CDR-SB score went up 1.21 points in the lecanemab group, compared with 1.66 in the placebo group. Overall, there were serious adverse events in 14% of the lecanemab group and 11.3% of the placebo group. The researchers also wrote that about 0.7% of participants in the lecanemab group and 0.8% of those in the placebo group died, corresponding to six deaths documented in the lecanemab group and seven in the placebo group.
0 next >>
Total: 3